Breast Cancer News and Research

Latest Breast Cancer News and Research

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

deCODE genetics, Inc. (Nasdaq: DCGN) today announced that it has filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code with the United States Bankruptcy Court for the District of Delaware to facilitate the sale of substantially all of its assets. deCODE is continuing to operate its business and manage its properties as a debtor-in-possession pursuant to Sections 1107 and 1108 of the Bankruptcy Code.

17 Nov 2009

Genentech submits sBLAs to the FDA for Avastin

Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.

17 Nov 2009

HDAC inhibitors: New therapy for treating breast cancer

A powerful new breast cancer treatment could result from packaging one of the newer drugs that inhibits cancer's hallmark wild growth with another that blocks a primordial survival technique in which the cancer cell eats part of itself, researchers say.

17 Nov 2009

Enrollment complete in Cytori Therapeutics' international breast cancer reconstruction study

Cytori Therapeutics completed enrollment in a 70-patient, international breast cancer reconstruction study, RESTORE 2. The study is evaluating the use of cell-enriched fat grafting to restore functional and cosmetic deformities in women who have undergone partial mastectomy for early breast cancer.

16 Nov 2009

Genta announces financial results for the third quarter of 2009, reduces workforce to cut payroll costs

Genta Incorporated today announced financial results for the quarter and nine months ended September 30, 2009. The Company also announced a restructuring, reduction in workforce, and re-ordering of clinical development priorities.

16 Nov 2009

First Edition: October 16, 2009

News reports continue to focus on the landmines that exist within health reform proposals.

16 Nov 2009

Rethink Breast Cancer launches 2009 Breast Fest Film Festival

Rethink Breast Cancer is turning out the lights and putting boobies on the big screen at the 2009 Breast Fest Film Festival. After a successful inaugural year, the world's first breast cancer film festival is back in Toronto this weekend with a new selection of inspiring films that span the emotional spectrum of the breast cancer journey. As part of Breast Fest's expanded three-day program, Rethink will unveil more panel discussions and workshops to inspire dialogue, facilitate learning and foster community.

16 Nov 2009

HealthPartners' health plans ranked top in Minnesota

HealthPartners is among the top 25 best private health plans in the nation and the top ranked plan in Minnesota according to U.S. News & World Report/NCQA “America's Best Health Insurance Plans 2009-10.” The report measures how well health plans perform on 50 measures of health care and member satisfaction. Two hundred thirty nine health plans from across the nation are included in the report. The top 50 health plans, including HealthPartners, are listed in the Nov. 16, 2009 print edition of U.S. News & World Report.

16 Nov 2009

ART Advanced Research Technologies receives delisting notice from TSX

ART Advanced Research Technologies Inc., a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today announced that it will delay the release of its financial results for the third quarter ended September 30, 2009, considering the restructuring process that the company is currently undergoing.

16 Nov 2009

Study: Coffee might be effective to fight against colon cancer

A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists.

13 Nov 2009

Breast cancer patients who undergo fertility preservation need not delay treatment

A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion.

13 Nov 2009

New and effective medicines underway for treating a wide range of diseases affecting women

Women's Health Weekly recently reported that America's pharmaceutical research and biotechnology companies are working on nearly 1,000 life-changing medicines for diseases affecting women, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). The medicines are awaiting approval by the U.S. Food and Drug Administration or are in human clinical trials.

13 Nov 2009

Cancer patients with dense breasts have a higher risk of recurring malignancy

A study published in the current issue of Cancer found that breast cancer patients with dense breasts have a 4x higher risk of recurring malignancy.

13 Nov 2009

Tips for preventing cancer

The risk of cancer can be dramatically reduced through everyday choices about diet, exercise and tobacco use, according to a Special Report on Cancer Prevention in the November issue of Mayo Clinic Women's HealthSource.

12 Nov 2009

PIKAMAB announces the development of ADCC Therasight, a novel theragnostic product

PIKAMAB, a stratified medicine biopharmaceutical company, announced today that it is developing ADCC TherasightTM, a novel theragnostic product that can help guide the drug development process and patient treatment protocols for the cancer therapeutic antibodies that use ADCC (antibody-dependent cellular cytotoxicity) as the major mechanism of action.

12 Nov 2009

Researchers find link between two genes involved in cancer formation in humans

Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment.

11 Nov 2009

OncoVista Innovative Therapies' AdnaTest BreastCancer and EMT1/StemCell products evaluated in German hospitals

OncoVista Innovative Therapies, Inc. reported today that two of its proprietary products, the AdnaTest™ BreastCancer and AdnaTest EMT1/StemCell, were evaluated in Germany by the Departments of Gynecology and Obstetrics and Internal Medicine (Cancer Research) at University Hospital Essen, University of Duisburg-Essen and the Department of Gynecology and Obstetrics, University Hospital of Tuebingen.

11 Nov 2009

Capecitabine in chemotherapy regimen reduces early breast cancer recurrence

An analysis conducted by the Finnish Breast Cancer Group and published in The Lancet Oncology shows women at intermediate to high-risk of early breast cancer recurrence who received capecitabine as part of their chemotherapy regimen had a 34% reduction in the risk of the disease returning or death, compared with those taking the chemotherapy combination regimen without capecitabine.

11 Nov 2009

Poor access to interpreters can compromise doctor-patient communication in cancer care

In a new survey of physicians who treat breast cancer patients, only one-third said they had good access to trained medical interpreters or telephone language-interpretation systems when they needed it. Poor access to interpreters can compromise physician-patient communication that is critically important in cancer care.

11 Nov 2009

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Peregrine Pharmaceuticals, Inc. today announced that a newly published study shows that a phosphatidylserine (PS)-targeting antibody similar to the company's lead product candidate bavituximab demonstrated potent anti-tumor activity when combined with radiation in a model of aggressive brain cancer, doubling the survival time of test animals and producing long-term cures.

11 Nov 2009

Breast Cancer News and Research

Latest Breast Cancer News and Research

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

Genentech submits sBLAs to the FDA for Avastin

HDAC inhibitors: New therapy for treating breast cancer

Enrollment complete in Cytori Therapeutics' international breast cancer reconstruction study

Genta announces financial results for the third quarter of 2009, reduces workforce to cut payroll costs

First Edition: October 16, 2009

Rethink Breast Cancer launches 2009 Breast Fest Film Festival

HealthPartners' health plans ranked top in Minnesota

ART Advanced Research Technologies receives delisting notice from TSX

Study: Coffee might be effective to fight against colon cancer

Breast cancer patients who undergo fertility preservation need not delay treatment

New and effective medicines underway for treating a wide range of diseases affecting women

Cancer patients with dense breasts have a higher risk of recurring malignancy

Tips for preventing cancer

PIKAMAB announces the development of ADCC Therasight, a novel theragnostic product

Researchers find link between two genes involved in cancer formation in humans

OncoVista Innovative Therapies' AdnaTest BreastCancer and EMT1/StemCell products evaluated in German hospitals

Capecitabine in chemotherapy regimen reduces early breast cancer recurrence

Poor access to interpreters can compromise doctor-patient communication in cancer care

Peregrine Pharmaceuticals' bavituximab PS-targeting antibody demonstrates potent anti-tumor activity

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Breast Cancer News and Research

Latest Breast Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in